The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug ...

The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Doctors also say people shouldn't drive until they've had advice on some painkillers, which could make you drowsy and slow ...

From unexpected gender disparities to alarming teen statistics, discover essential facts about opioid medications that every ...

Paul Howe, chief commercial officer at Protega, discusses efforts to combine high tech solutions with pain-management medications.

Yale researchers found that cannabis-derived compounds CBD, CBG and CBN reduce pain signaling by inhibiting the Nav1.8 ...

Chronic pain is a global health challenge, with current treatment options often limited by side effects, addiction risk, and diminished effectiveness over time. In a new study, Yale researchers ...

Having lived with disabling chronic pain for 32 years, one reader discovered a lesser known treatment that has transformed ...

A recent study shows that the lack of trust is justified. Your doctor may be ignoring your pain. Here’s what you need to know ...